Acknowledgement
Supported by : National Research Foundation of Korea (NRF)
References
- Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101:3722-9. https://doi.org/10.1182/blood-2002-07-2104
- Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107:367-72. https://doi.org/10.1182/blood-2005-07-2657
- Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006;24:74-85. https://doi.org/10.1634/stemcells.2004-0359
-
Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE. Mesenchymal stem cells inhibit generation and function of both
$CD34^+$ -derived and monocyte-derived dendritic cells. J Immunol. 2006;177:2080-7. https://doi.org/10.4049/jimmunol.177.4.2080 - Di Ianni M, Del Papa B, De Ioanni M, Moretti L, Bonifacio E, Cecchini D, et al. Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol. 2008;36:309-18. https://doi.org/10.1016/j.exphem.2007.11.007
- Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383-96. https://doi.org/10.1038/nri3209
- Subbanna PK. Mesenchymal stem cells for treating GVHD: in vivo fate and optimal dose. Med Hypotheses. 2007;69:469-70. https://doi.org/10.1016/j.mehy.2006.12.016
- Wagner W, Bork S, Lepperdinger G, Joussen S, Ma N, Strunk D, et al. How to track cellular aging of mesenchymal stromal cells? Aging (Albany NY). 2010;2:224-30.
- Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem. 2006;99:1285-97. https://doi.org/10.1002/jcb.20904
- Kern S, Eichler H, Stoeve J, Klu ter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294-301. https://doi.org/10.1634/stemcells.2005-0342
- Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 2009;259:150-6. https://doi.org/10.1016/j.cellimm.2009.06.010
- Zhuang Y, Li D, Fu J, Shi Q, Lu Y, Ju X. Comparison of biological properties of umbilical cord-derived mesenchymal stem cells from early and late passages: immunomodulatory ability is enhanced in aged cells. Mol Med Rep. 2015;11:166-74. https://doi.org/10.3892/mmr.2014.2755
- Heo JS, Choi Y, Kim HS, Kim HO. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37:115-25. https://doi.org/10.3892/ijmm.2015.2413
- Pourgholaminejad A, Aghdami N, Baharvand H, Moazzeni SM. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells. Cytokine. 2016;85:51-60. https://doi.org/10.1016/j.cyto.2016.06.003
- Pawitan JA. Prospect of adipose tissue derived mesenchymal stem cells in regenerative medicine. Cell Tissue Transpl Ther. 2009;2:7-9. https://doi.org/10.4137/CTTT.S3654
- Strem BM, Hicok KC, Zhu M, Wulur I, Alfonso Z, Schreiber RE, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med. 2005;54:132-41. https://doi.org/10.2302/kjm.54.132
- Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One. 2008;3:e2213. https://doi.org/10.1371/journal.pone.0002213
- Thejaswi K, Amarnath M, Srinivas G, Jerald MK, Avinash Raj T, Singh S. Immune modulatory responses of mesenchymal stem cells from different sources in cultures and in vivo. Cell Tissue Transpl Ther. 2012;4:1-13.
- Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, Apparailly F, et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells. 2007;25:2025-32. https://doi.org/10.1634/stemcells.2006-0548
- Varma TK, Toliver-Kinsky TE, Lin CY, Koutrouvelis AP, Nichols JE, Sherwood ER. Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice. Infect Immun. 2001;69:5249-63. https://doi.org/10.1128/IAI.69.9.5249-5263.2001
- Rubtsov YP, Rudensky AY. TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol. 2007;7:443-53. https://doi.org/10.1038/nri2095
- Tsai TL, Li WJ. Identification of bone marrow-derived soluble factors regulating human mesenchymal stem cells for bone regeneration. Stem Cell Reports. 2017;8:387-400. https://doi.org/10.1016/j.stemcr.2017.01.004
- Teshima T, Matsumoto H, Koyama H. Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion. PLoS One. 2018;13:e0191539. https://doi.org/10.1371/journal.pone.0191539
- Ko JH, Lee HJ, Jeong HJ, Kim MK, Wee WR, Yoon SO, et al. Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye. Proc Natl Acad Sci U S A. 2016;113:158-63. https://doi.org/10.1073/pnas.1522905113
- Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology. 2000;101:191-200. https://doi.org/10.1046/j.1365-2567.2000.00109.x
- Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF, et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood. 2010;116:935-44.
- Woodward EA, Prele CM, Nicholson SE, Kolesnik TB, Hart PH. The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1). Immunology. 2010;131:118-27.
- Gieseke F, Bohringer J, Bussolari R, Dominici M, Handgretinger R, Mu ller I. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood. 2010;116:3770-9.
- Wang J, Xia J, Zhang F, Shi Y, Wu Y, Pu H, et al. Galectin-1-secreting neural stem cells elicit long-term neuroprotection against ischemic brain injury. Sci Rep. 2015;5:9621. https://doi.org/10.1038/srep09621
- Sioud M, Mobergslien A, Boudabous A, Floisand Y. Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation. Scand J Immunol. 2010;71:267-74. https://doi.org/10.1111/j.1365-3083.2010.02378.x
- Tsai HF, Wu CS, Chen YL, Liao HJ, Chyuan IT, Hsu PN. Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis. J Mol Med (Berl). 2016;94:545-56. https://doi.org/10.1007/s00109-015-1368-x
Cited by
- Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling vol.9, pp.None, 2019, https://doi.org/10.1038/s41598-019-43638-0
- The Immunomodulatory Potential of Wharton’s Jelly Mesenchymal Stem/Stromal Cells vol.2019, pp.None, 2019, https://doi.org/10.1155/2019/3548917
- Genetic Stability of Mesenchymal Stromal Cells for Regenerative Medicine Applications: A Fundamental Biosafety Aspect vol.20, pp.10, 2018, https://doi.org/10.3390/ijms20102406
- The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration: A Review vol.1, pp.4, 2018, https://doi.org/10.1089/bioe.2019.0026
- Molecular Mechanisms Contributing to Mesenchymal Stromal Cell Aging vol.10, pp.2, 2020, https://doi.org/10.3390/biom10020340
- Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells vol.21, pp.3, 2018, https://doi.org/10.3390/ijms21031086
- Infusion of Mesenchymal Stem Cells to Treat Graft Versus Host Disease: the Role of HLA-G and the Impact of its Polymorphisms vol.16, pp.3, 2018, https://doi.org/10.1007/s12015-020-09960-1
- Targeted Delivery of Mesenchymal Stem Cell-Derived Nanovesicles for Spinal Cord Injury Treatment vol.21, pp.11, 2020, https://doi.org/10.3390/ijms21114185
- Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice vol.2021, pp.None, 2018, https://doi.org/10.1155/2021/6546780
- Comparison of the Cytokine Profile in Mesenchymal Stem Cells from Human Adipose, Umbilical Cord, and Placental Tissues vol.23, pp.6, 2018, https://doi.org/10.1089/cell.2021.0043